Literature DB >> 8267717

Acute circulatory support.

M J Barnard1, S P Linter.   

Abstract

Numerous drugs can increase cardiac output, thereby improving tissue oxygen delivery, but often they do this at the expense of increasing myocardial oxygen demand. This may be critical when cardiac function is substantially impaired or ischaemia is the precipitating cause. Using polypharmacy to substantially improve cardiovascular status requires detailed knowledge of the pharmacodynamics and interactions of the available agents so that they may be tailored to the individual patient. In some settings combinations of inotropes and vasodilators may be desirable to minimise cardiac workload. In other instances vasopressors may be necessary to urgently restore a minimum perfusion pressure. This paper reviews the use of this group of drugs as well as the mechanical assist devices that may be used when drugs fail.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267717      PMCID: PMC1678508          DOI: 10.1136/bmj.307.6895.35

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  56 in total

1.  The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs.

Authors:  R R Tuttle; G D Pollock; G Todd; B MacDonald; R Tust; W Dusenberry
Journal:  Circ Res       Date:  1977-09       Impact factor: 17.367

2.  The spontaneous occurrence of paroxysmal supraventricular tachycardia.

Authors:  E L Pritchett; M S Smith; E A McCarthy; K L Lee
Journal:  Circulation       Date:  1984-07       Impact factor: 29.690

3.  Augmentation of cardiac function by elevation of intrathoracic pressure.

Authors:  M R Pinsky; W R Summer; R A Wise; S Permutt; B Bromberger-Barnea
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-04

4.  Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.

Authors:  M A Konstam; S R Cohen; D S Weiland; T T Martin; D Das; J M Isner; D N Salem
Journal:  Am J Cardiol       Date:  1986-02-01       Impact factor: 2.778

5.  Norepinephrine plus phentolamine improves regional blood flow during experimental low cardiac output syndrome.

Authors:  J H Lemmer; M J Botham; P McKenney; R A Gerren; M M Kirsh; K P Gallagher
Journal:  Ann Thorac Surg       Date:  1984-08       Impact factor: 4.330

6.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

7.  Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy.

Authors:  G L Schaer; M P Fink; J E Parrillo
Journal:  Crit Care Med       Date:  1985-06       Impact factor: 7.598

8.  Alpha and beta adrenergic effects of the stereoisomers of dobutamine.

Authors:  R R Ruffolo; T A Spradlin; G D Pollock; J E Waddell; P J Murphy
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

9.  Effects of dobutamine in patients with acute myocardial infarction.

Authors:  T A Gillespie; H D Ambos; B E Sobel; R Roberts
Journal:  Am J Cardiol       Date:  1977-04       Impact factor: 2.778

10.  Prostaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement.

Authors:  M N D'Ambra; P J LaRaia; D M Philbin; W D Watkins; A D Hilgenberg; M J Buckley
Journal:  J Thorac Cardiovasc Surg       Date:  1985-04       Impact factor: 5.209

View more
  2 in total

1.  Acute circulatory support. Noradrenaline may preserve renal function.

Authors:  W D Plant; A D Cumming
Journal:  BMJ       Date:  1993-08-21

2.  Acute circulatory support. Dopamine's renal effects are complex.

Authors:  A M Cohen
Journal:  BMJ       Date:  1993-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.